FDA Authorizes Surgical Robot Designed For Transvaginal Hysterectomies

FierceBiotech (3/2, Hale) reports the FDA has “cleared its first surgical robot designed for transvaginal hysterectomies, a minimally invasive option that aims for a faster recovery time compared to procedures that require a larger abdominal incision.” FierceBiotech adds, “Memic Innovative Surgery’s Hominis system is intended to assist with the removal of the uterus, along with one or both of the fallopian tubes and ovaries, in cases where there is no cancer present, as well as with the removal of ovarian cysts.” Under its “de novo clearance, the FDA is requiring Memic to provide comprehensive training programs for surgeons and operating room staff before they can operate the device.”